CG
IRWD icon

Cutler Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cutler Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,300
Closed -$54K – 4956
2020
Q2 		$54K Buy
5,300
+100
+2% +$1.02K ﹤0.01% 1690
2020
Q1 		$52K Buy
+5,200
New +$61.1K ﹤0.01% 1696
2018
Q4 		– Sell
-322
Closed -$4K – 4243
2018
Q3 		$4K Sell
322
-359
-53% -$5.67K ﹤0.01% 3175
2018
Q2 		$10K Buy
+681
New +$10.1K ﹤0.01% 2675
2017
Q3 		– Sell
-1,071
Closed -$14.7K – 6240
2017
Q2 		$16K Buy
+1,071
New +$15.6K ﹤0.01% 3643
2017
Q1 		– Sell
-119
Closed -$1.63K – 6765
2016
Q4 		$1K Buy
+119
New +$1.5K ﹤0.01% 6020
2016
Q1 		– Sell
-164
Closed -$1.35K – 6812
2015
Q4 		$1K Buy
+164
New +$1.58K ﹤0.01% 5966

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cutler Group's IRWD Position: Q3 2020 in Review

Cutler Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 5,300 shares — an estimated $54K sold.

Cutler Group first reported a position in IRWD in Q4 2015 and held it in 7 quarters. The position peaked at $54K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • Cutler Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cutler Group sold 5,300 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $54K.
  • Cutler Group first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Ironwood Pharmaceuticals position peaked at $54K in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.